CapsoVision, Inc. operates as a commercial-stage medical technology company. The company is headquartered in Saratoga California, California. The company went IPO on 2025-07-02. Its flagship product, CapsoCam Plus, is a small bowel capsule endoscope that uses a novel 360 panoramic lateral view to overcome the limitations of end-facing cameras and provide a more comprehensive imaging solution, while its wire-free design provides unparalleled comfort and convenience to patients. Its CapsoCloud is a next generation, cloud-based software application that makes clinical data management convenient and secure. Its capsule collection kit is a sanitary, single-use kit provided to patients for the collection, storage and transportation of the CapsoCam Plus capsule.
Follow-Up Questions
CapsoVision Inc 的 CEO 是谁？
Mr. Kang-Huai Wang 是 CapsoVision Inc 的 President，自 2006 加入公司。
CV 股票的价格表现如何？
CV 的当前价格为 $4.84，在上个交易日 decreased 了 0%。
CapsoVision Inc 的主要业务主题或行业是什么？
CapsoVision Inc 属于 Health Care 行业，该板块是 Health Care
